At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Olanzapine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
In Brief
A Phase 4 clinical trial evaluating Olanzapine and Aripiprazole for Diabetes. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This study will examine the effects of two different antipsychotic medications on control of blood sugar in people who are at risk of diabetes but mentally healthy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedMay 2009
Primary CompletionDec 2009
Study CompletionJun 2010
TodayJul 2026
First PostedMay 8, 2009
Enrollment StartNov 1, 2008
Primary CompletionDec 1, 2009
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 17.2 years ago
Interventions
Olanzapinedrug
Single intramuscular 10-mg dose
Aripiprazoledrug
Single intramuscular 9.75-mg dose